Form 4: DexCom Executive Reports Stock Transaction

Michael Jon Brown, EVP Chief Legal Compliance Officer at DexCom Inc., reported a transaction involving common stock on May 22, 2026.

Summary

• Michael Jon Brown, EVP Chief Legal Compliance Officer of DexCom Inc., engaged in a transaction involving common stock on May 22, 2026.
• The transaction involved 1,451 shares of common stock, acquired at a price of $71.90 per share.
• This acquisition was to cover tax withholding obligations related to the net settlement of restricted stock units.
• Following this transaction, Mr. Brown beneficially owns 108,053 shares of common stock.
• The reported holdings include 74,753 unvested restricted stock units with various vesting schedules through March 8, 2029.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine tax withholding transaction for an executive and does not indicate a change in the executive's investment or the company's performance.

Positives

• The transaction was for tax withholding purposes, indicating a standard procedure for executive compensation rather than a sale.
• The executive continues to hold a significant number of shares (108,053) and unvested restricted stock units, suggesting continued commitment to the company.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions and do not typically provide strategic insights. The details here relate to standard executive compensation practices within the medical device technology sector.

Stakeholder Impact

• Shareholders: The transaction is a standard tax withholding, so it is unlikely to have a direct impact on the share price or shareholder value.

Key Dates

Keywords

DexCom Inc, DXCM, Form 4, SEC Filing, Stock Transaction, Executive Compensation, Restricted Stock Units, Beneficial Ownership, Michael Jon Brown